Company · CIK 1818838
Adagene Inc.
| CIK | 1818838 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | China |
| Listed | ADAG (Nasdaq) |
| First annual or quarterly report | 2021-04-28 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-287161 | 2025-05-09 | 2026-04-02 | 5 | |
| 333-291196 | 2025-10-31 | 2026-01-09 | 2 | |
| 333-264486 | 2022-04-26 | 2024-03-29 | 3 | |
| 333-252210 | 2021-01-19 | 2021-02-10 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-02 | 424B5Shelf takedown | 333-287161 | 0001104659-26-039189 |
| 2026-04-02 | 424B5Shelf takedown | 333-287161 | 0001104659-26-038861 |
| 2026-01-09 | EFFECTDeclared effective | 333-291196 | 9999999995-26-000134 |
| 2025-10-31 | F-3Shelf registered | 333-291196 | 0001104659-25-104934 |
| 2025-05-30 | EFFECTDeclared effective | 333-287161 | 9999999995-25-001796 |
| 2025-05-30 | 424B5Shelf takedown | 333-287161 | 0001104659-25-054974 |
| 2025-05-09 | F-3Shelf registered | 333-287161 | 0001104659-25-046772 |
| 2024-03-29 | 424B5Shelf takedown | 333-264486 | 0001104659-24-041120 |
| 2022-05-26 | EFFECTDeclared effective | 333-264486 | 9999999995-22-001602 |
| 2022-04-26 | F-3Shelf registered | 333-264486 | 0001104659-22-050362 |
| 2021-02-10 | 424B4Final prospectus | 333-252210 | 0001047469-21-000331 |
| 2021-02-08 | EFFECTDeclared effective | 333-252543 | 9999999995-21-000506 |
| 2021-02-08 | EFFECTDeclared effective | 333-252210 | 9999999995-21-000497 |
| 2021-02-05 | F-1/AAmendment | 333-252210 | 0001047469-21-000297 |
| 2021-02-03 | F-1/AAmendment | 333-252210 | 0001047469-21-000256 |
| 2021-02-01 | F-1/AAmendment | 333-252210 | 0001047469-21-000233 |
| 2021-01-19 | F-1Registration filed | 333-252210 | 0001047469-21-000130 |
| 2020-09-22 | DRSDraft made public | 377-03582 | 0001104659-20-107433 |